首页 | 本学科首页   官方微博 | 高级检索  
   检索      

利用RNAi抑制PARs防治脑缺血性损伤的实验研究
引用本文:王莹,祝萍,王昆祥,姜海智,王旭东,姜宏佺,郑永慧.利用RNAi抑制PARs防治脑缺血性损伤的实验研究[J].生物磁学,2011(22):4256-4259.
作者姓名:王莹  祝萍  王昆祥  姜海智  王旭东  姜宏佺  郑永慧
作者单位:[1]哈尔滨医科大学第一医院干部病房,150023 [2]哈尔滨红十字中心医院急诊科,150076 [3]佳木斯大学附属第一医院神经内科,154007 [4]哈尔滨医科大学第一医院神经内科 ,154007 [5]哈尔滨医科大学第四医院神经内科,黑龙江哈尔滨150001
摘    要:目的:利用RNA干扰技术,通过重组腺病毒导入,抑制脑组织中PARs基因的表达,观察神经功能缺陷评分、缺血脑组织梗死体积的变化,为缺血性脑血管疾病的基因治疗提供实验依据。方法:雄性Wistar大鼠随机分组。以重组腺病毒介导的无序PARs基因shRNA片段、生理盐水进行干预,干预3天后以线栓法建立Wistar大鼠大脑中动脉永久闭塞模型,各组分别于线栓后24h、72h进行神经功能缺陷评分并断头取脑,应用4%TTC染色测脑梗死体积。结果:1.缺血后24h、72h同一时间点:①实验组分别与对照组、生理盐水组对比,神经功能缺陷评分明显降低(P〈0.05),脑梗死体积明显减小(P〈0.05);②对照组与生理盐水组对比,神经功能缺陷评分、脑梗死体积无明显差异(P〉0.05)。2.各组组内缺血后24h、72h对比,神经功能缺陷评分、脑梗死体积各组均有明显差异(P〈0.05)。结论:重组腺病毒介导的RNAi能有效抑制脑组织中PARs基因的表达,缩小脑梗死体积,改善神经功能缺陷评分。

关 键 词:RNAi  PARs  重组腺病毒  脑缺血

Research on Inhibition of PARs Gene Expression by RNAi Attenuates Ischemic Brain Injury
WANG Yin,ZHU Ping,WANG Kun-xiang,JIANG Hai-zhi,WANG Xu-dong,JIANG Hong-quan,ZHENG Yong-hui.Research on Inhibition of PARs Gene Expression by RNAi Attenuates Ischemic Brain Injury[J].Biomagnetism,2011(22):4256-4259.
Authors:WANG Yin  ZHU Ping  WANG Kun-xiang  JIANG Hai-zhi  WANG Xu-dong  JIANG Hong-quan  ZHENG Yong-hui
Institution:1 The 1st clinical hospital of Harbin medical university, VIP department 150023; 2 Harbin red-cross center hospital, emergency department 150076; 3 The 1st clinical hospital of Jiamusi medical university, neurology department 154007; 4 The 1st clinical hospital of Harbin medical university, neurology department," 5 The 4th clinical hospital of Harbin medical university, neurology department 150001)
Abstract:Objective: To investigate the neuron-protection effects of brain ischemia on gene expression inhibition of recombinant adeno-associated virus (rAAV)-mediated gene transfer to ischemic brain, and to provide basic evidence for gene therapy on cerebral ischemia. Meflaod: 84 adult male Wistar rats between 16 and 20 weeks of age and weighing 220 to 280g were randomly divided into three groups: the experimental group (EG), the control group (CG), the physiological sodium group (PSG). The rats were given rAAV-RPARs-shRNA in proper sequence, rAAV-RPARs-shRNA in disturbed sequence, sodium chloride 3 days before performing mid- dle cerebral artery occlusion (MCAO). 24 or 72 hours after ischemia all rats were performed neurological evaluation and then decapitated. We determined brain infarct volume by 2,3,5-triphenyltetrazolium chloride (TTC) staining. Result: (L)At the same time point, 24 or 72 hours aider ischemia, the grade of neuro-functional deficit in the experiment group (EG) decreased compared with that in the control group (CG)(P〈0.05), and the volume of cerebral infarction was strikingly diminuted (P〈0.05); the grade of neuro-functional deficit in the experiment group (EG) decreased compared with that in the physiological saline group (PSG) (P〈0.05), and the volume of cerebral in- farction was strikingly diminuted (P〈0.05); But when we compared the CG with the PSG, we found that there were no obvious differ- ences of indexes above between these two groups (P〉0.05).(2)At different time point the grade of neuro-functional deficit decreased com- pared with each other inner groups (P〈0.05), and the volume of cerebral infarction was strikingly diminuted (P〈0.05); Conclusions: rAAV-mediated RNA interference could actively suppress the expression of PARs in brain tissues, thereby diminute cerebral infarction volume and improve the grade of neuro-functional deficit.
Keywords:RNA interference (RNAi)  Protease activated receptors (PARs)  Recombinant adeno-associated virus(rAAV)  Ischemia
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号